Immunogenicity of a combined diphtheria–tetanus–acellular pertussis vaccine in adults

P Van Damme, M Burgess - Vaccine, 2004 - Elsevier
Two clinical studies were undertaken to evaluate the immunogenicity of an adult-type dTpa
booster vaccine (Boostrix™ by GlaxoSmithKline Biologicals). Blood samples taken prior to …

Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-inactivated polio vaccine-Haemophilus influenzae type b vaccine administered at 2-4 …

RM Carlsson, BA Claesson, U Selstam… - The Pediatric …, 1998 - journals.lww.com
Methods. In an open randomized study we compared the safety and immunogenicity of two
schedules for priming and booster vaccinations of infants. A pentavalent combination …

Post-marketing surveillance of Tetravalent Diphtheria-Tetanus-Acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine in South Korea, 2009 to 2015

YJ Choe, E Vidor, C Manson - Infectious Diseases and Therapy, 2022 - Springer
Abstract Introduction TETRAXIM™(Sanofi), a combined diphtheria, tetanus, acellular
pertussis, and inactivated poliovirus (DTaP-IPV) vaccine, has been licensed in South Korea …

[HTML][HTML] Safety and immunogenicity of a hexavalent DTwP-IPV-HB-PRP∼ T vaccine versus separate DTwP-HB-PRP∼ T and IPV vaccines in healthy infants in India

S Mangarule, S Palkar, M Mitra, MD Ravi, AP Dubey… - Vaccine: X, 2022 - Elsevier
Background Multivalent vaccines containing whole-cell pertussis (wP) antigens combined
with established diphtheria (D), tetanus (T), hepatitis B (HB), Haemophilus influenzae type b …

Notes from the field: use of tetanus, diphtheria, and pertussis vaccine (Tdap) in an emergency department-Arizona, 2009-2010

Centers for Disease Control and … - MMWR. Morbidity …, 2012 - pubmed.ncbi.nlm.nih.gov
Because of an increasing incidence of reported pertussis cases attributed to waning
immunity among adults and adolescents, the Advisory Committee on Immunization Practices …

Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP–IPV) vaccine

MF Daley, WK Yih, JM Glanz, SJ Hambidge… - Vaccine, 2014 - Elsevier
Background In 2008, a diphtheria, tetanus, acellular pertussis, and inactivated poliovirus
combined vaccine (DTaP–IPV) was licensed for use in children 4 through 6 years of age …

Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed …

SA Halperin, S McNeil, J Langley, M Blatter, M Dionne… - Vaccine, 2011 - Elsevier
BACKGROUND: Although decennial adult boosters of tetanus and diphtheria toxoids are
recommended in Canada and the United States, a second dose of pertussis vaccine is not …

[HTML][HTML] Post-marketing surveillance to assess the safety and tolerability of a combined diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine …

SM Lee, SJ Kim, J Chen, JH Kim… - Human Vaccines & …, 2019 - Taylor & Francis
ABSTRACT Infanrix-IPV (GSK, Belgium) is a diphtheria, tetanus, acellular pertussis, and
inactivated poliovirus combination vaccine (DTaP-IPV) licensed in many countries including …

Shortened interval between tetanus vaccines

AE Lodolce - Annals of Pharmacotherapy, 2012 - journals.sagepub.com
OBJECTIVE: To identify the minimum safe interval between tetanus-diphtheria (Td) and
tetanus-diphtheria-acellular pertussis (Tdap) vaccines. DATA SOURCES: Literature was …

[HTML][HTML] Coverage rates for diphtheria, tetanus, poliomyelitis, and pertussis age-specific booster recommendations in France: 2018 update of the real-world cohort …

R Verdier, C Marchal, M Belhassen, M Le Pannerer… - Infectious Medicine, 2023 - Elsevier
Abstract The French National Immunization Program was updated in 2013 for vaccination
against diphtheria, tetanus, pertussis, and poliomyelitis. Our previous findings on the …